During the last session, Caribou Biosciences Inc (NASDAQ:CRBU)’s traded shares were 1.25 million, with the beta value of the company hitting 2.44. At the end of the trading day, the stock’s price was $1.28, reflecting an intraday gain of 10.34% or $0.12. The 52-week high for the CRBU share is $3.00, that puts it down -134.38 from that peak though still a striking 48.44% gain since the share price plummeted to a 52-week low of $0.66. The company’s market capitalization is $119.05M, and the average trade volume was 1.10 million shares over the past three months.
Caribou Biosciences Inc (CRBU) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.44. CRBU has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it.
Caribou Biosciences Inc (NASDAQ:CRBU) trade information
Caribou Biosciences Inc (CRBU) registered a 10.34% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 10.34% in intraday trading to $1.28, hitting a weekly high. The stock’s 5-day price performance is 8.47%, and it has moved by 21.90% in 30 days. Based on these gigs, the overall price performance for the year is -28.49%.
The consensus price target of analysts on Wall Street is $3, which implies an increase of 57.33% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $3 and $3 respectively. As a result, CRBU is trading at a discount of -134.38% off the target high and -134.38% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -33.41%. While earnings are projected to return 4.47% in 2025, the next five years will return 11.15% per annum.
CRBU Dividends
Caribou Biosciences Inc is due to release its next quarterly earnings on 2025-May-08. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Caribou Biosciences Inc (NASDAQ:CRBU)’s Major holders
Caribou Biosciences Inc insiders own 9.83% of total outstanding shares while institutional holders control 53.30%, with the float percentage being 59.11%. BLACKROCK INC. is the largest shareholder of the company, while 169.0 institutions own stock in it. As of 2024-06-30, the company held over 6.95 million shares (or 7.6907% of all shares), a total value of $11.39 million in shares.
The next largest institutional holding, with 4.54 million shares, is of VANGUARD GROUP INC’s that is approximately 5.0306% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $7.45 million.
